Enrofloxacin (Compound)

Synonyms:Enrofloxacin, 93106-60-6, Baytril, Enrofloxacine, CFPQ, Enrofloxacino, Enrofloxacinum, BAY VP 2674, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, Enroxil, UNII-3DX3XEK1BN, Baytril (TN), N-Ethylciprofloxacin, ERFX, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, C19H22FN3O3, MFCD00792463, 3DX3XEK1BN, 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-, MLS000069441, CHEBI:35720, BAY Vp 2674;PD160788, endrofloxicin, NCGC00018143-04, CPD000059011, PD160788, SMR000059011, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid, DSSTox_CID_25619, DSSTox_RID_81007, DSSTox_GSID_45619, 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-, Enrofloxacine [French], Enrofloxacinum [Latin], Enrofloxacino [Spanish], Bay-Vp-2674, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid, CAS-93106-60-6, Enrofloxacin [USAN:BAN:INN], HSDB 6952, BRN 5307824, CCRIS 8214, Enrofloxacin [USAN:USP:INN:BAN], Enrofloxacin-[d5], Opera_ID_1106, Enrofloxacin (USP/INN), Enrofloxacin (USAN/INN), 1,4-Dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid, BAY-Vp2674, MLS001076496, MLS001424169, CHEMBL15511, SCHEMBL149150, SPECTRUM1503721, DTXSID1045619, HMS2052O09, HMS2090E12, HMS2093I21, HMS2234M11, HMS3373P14, HMS3394O09, HMS3715B18, Pharmakon1600-01503721, ZINC597112, ALBB-030792, BCP15457, HY-B0502, Enrofloxacin, >=98.0% (HPLC), Tox21_110831, BBL009982, DL-384, HTS028366, NSC758616, s3059, STK711109, AKOS005530685, BAY-Vp2674;PD160788, Tox21_110831_1, AC-7614, CCG-101102, DB11404, KS-5010, MCULE-6446074322, NC00352, NSC 758616, NSC-758616, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-quinoline-3-carboxylic acid, 1-cyclopropyl-7-(4-ethylpiperazinyl)-6-fluoro-4-oxohydroquinoline-3-carboxylic acid, NCGC00018143-01, NCGC00018143-02, NCGC00018143-03, NCGC00018143-05, NCGC00021632-03, H734, SBI-0206725.P001, AB0013220, DB-057368, B1742, E0786, FT-0625663

Pubchem:PUBCHEM:71188

Id:71188

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Enrofloxacin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Enrofloxacin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Enrofloxacin.

Results found

Linked to

	Label	Description
	BRD-K76534306-001-11-0 Substance (Entity type)	A Substance
	DCSTRUCT ID 05532 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05532; PubChem_CID:71188, FILE=drugcentral_drug_05532.json)
	enrofloxacin (091bc95c-6446-4511-9868-7fd290d3d7af) Collection (Entity type)	Metadatata for enrofloxacin
	Enrofloxacin positively regulates RRS1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Dephostatin in similarity relationship with Enrofloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Enrofloxacin positively regulates JMJD6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Enrofloxacin in similarity relationship with GW-1929 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	pirinixic acid in similarity relationship with Enrofloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Enrofloxacin negatively regulates F2RL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Enrofloxacin positively regulates MYB Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS